What Sharp Services does

Sharp Services is a privately held US-headquartered pharmaceutical contract services company operating a global network of GMP-registered facilities across the United States (Allentown, Bethlehem, Conshohocken, Macungie, Lee), the United Kingdom (Rhymney), Belgium (Hamont-Achel), and the Netherlands (Heerenveen). Founded in 1952 and now employing more than 2,500 people, Sharp is organized around three integrated service lines: sterile manufacturing (aseptic fill-finish for vials, syringes, cartridges, and lyophilized products, anchored by the 2023 acquisition of Berkshire Sterile Manufacturing), clinical trial services (manufacturing, comparator sourcing, packaging, labeling, IRT/IMS technology via the proprietary Clinteract and Clinventory platforms, storage, distribution, EU/UK QP release, and gene therapy support), and commercial packaging (blisters, bottles, injectables assembly, serialization, kitting, and sustainable packaging). The company serves biopharmaceutical companies, clinical trial sponsors, and commercial-stage pharma clients across North America, Europe, and Asia-Pacific, with named top-10 pharma customers and a China presence operated through the 2022 ClinsChain partnership. The integrated offering spans preclinical through commercial lifecycle stages, supported by technology partnerships with Werum (PAS-X MES), Veeva (QualityOne), TraceLink, and Systech.

Sharp's business model is a B2B managed-services contract structure with quote-based pricing tailored to drug type, volume, and service scope. Revenue is generated through service contracts for manufacturing, packaging, and clinical supply activities performed at Sharp-owned GMP facilities on behalf of pharma and biotech clients. The go-to-market motion is enterprise field sales with technical consultation, supported by participation in industry events including CPHI, BIO, Pharmapack, CDMO Live, and PODD. Quality and regulatory compliance is foundational — facilities hold FDA, MHRA, EU GMP, ANVISA, and Russian Federation certifications, and Sharp is a founding member of the Alliance to Zero sustainability consortium. Recent capital actions include a $100 million US/EU facility investment announced in October 2025 and a $28 million expansion of the Lee, Massachusetts sterile manufacturing site, alongside a 2022 funding event of $712.5 million, signaling an active growth investment posture.

Name

Sharp Services

Legal name

Sharp Services, LLC

Website

https://sharpservices.com

Company type

Private

Founded year

1952

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Sharp Services is a private US-headquartered pharmaceutical CDMO operating GMP facilities in the US, UK, Belgium, and Netherlands, providing sterile fill-finish, clinical trial supply, and commercial packaging services to biopharmaceutical companies and top-10 pharma clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing and Packaging Services (CDMO)

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Packaging and Labeling Services (561910)

SIC

Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Services-Health Services (8000)

akta.pro primary industry

Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH)

akta.pro secondary industries

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK), Packaging, Labeling & Serialization (Clinical/Commercial) CDMO (HLAGABAJ), Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Process Development & Tech Transfer Services (CDMO) (HLAGABAL)

Keywords

• Pharmaceutical contract packaging
• Sterile fill-finish services
• Clinical trial supply
• Biopharmaceutical manufacturing
• Aseptic manufacturing services

Headquarters

HQ city

Allentown

HQ country

United States

HQ region

North America

Offices9 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Manufacturing and Services: Sharp operates as a contract pharmaceutical company providing integrated services including sterile manufacturing, clinical trial supply, and commercial packaging to pharma and biotech clients. Revenue is generated through service contracts for manufacturing, packaging, and clinical supply services performed at client request.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels9 records

Core offering

Sharp Services is a global pharmaceutical contract development and manufacturing organization (CDMO) providing integrated services spanning the drug product lifecycle. The company delivers three core offerings: Sterile Manufacturing Services (aseptic fill-finish for vials, syringes, cartridges, plus lyophilization and analytical services), Clinical Trial Services (preclinical to commercial supply chain including manufacturing, packaging, labeling, IRT/IMS, comparator sourcing, and gene therapy support), and Commercial Packaging Services (primary and secondary packaging, serialization, and aggregation for marketed products).

Product overview

Sharp Services is a global pharmaceutical contract services company offering an integrated portfolio of three core service lines: Sterile Manufacturing Services, Clinical Trial Services, and Commercial Packaging Services. The company's offering is structured as a platform-plus-modules architecture, where clients can access individual services or integrated solutions spanning the drug lifecycle. Sterile Manufacturing Services provides aseptic fill-finish solutions including vial, syringe, and cartridge filling, lyophilization, and analytical services. Clinical Trial Services encompasses product development, manufacturing, analytical release, comparator sourcing, packaging, labeling, storage/distribution, IRT/IMS solutions (Clinteract, Clinventory), QP services, and gene therapy support. Commercial Packaging Services delivers primary and secondary packaging including blisters, bottles, injectables assembly, serialization, and sustainable packaging solutions. The three service lines are designed to work together, enabling Sharp to support clients from preclinical phases through commercial launch and lifecycle management.

Differentiator

Problem solved

Functional benefit

Brands

• Clinteract: Clinical trial technology solution for inventory management and clinical supply chain optimization.
• Clinventory

Products and services

• Sterile Manufacturing Services Aseptic fill-finish solutions for sterile injectable drug products including vial filling, syringe filling, cartridge filling, lyophilization, terminal steam sterilization, formulation development, lyophilization development, method development, stability programs, and analytical services. Served biopharmaceutical and pharmaceutical clients needing sterile injectable manufacturing from clinical through commercial supply.
• Clinical Trial Services Comprehensive clinical supply chain services from preclinical through commercial launch, including pharmaceutical product development, clinical trial manufacturing, analytical services, comparator drug supply, primary packaging, labeling and secondary packaging, storage and distribution, direct-to-patient services, IRT/IMS technology solutions, EU and UK Qualified Person services, clinical project management, drug supply manager consultancy, and gene therapy clinical trial services. Targeted at pharma and biotech sponsors running Phase I through Phase III and commercial trials.
• Commercial Packaging Services Primary and secondary pharmaceutical packaging solutions including blister packaging (cold and thermoform), bottling and packaging, injectables assembly/labeling/packaging (vials, pre-filled syringes, autoinjectors, pens, YpsoMate devices), pouches and sachets, kitting, sustainable packaging solutions, pharmaceutical packaging design services, and serialization and aggregation solutions. Served pharmaceutical companies with marketed products requiring commercial-scale packaging.
• Clinteract Sharp's Interactive Response Technology (IRT) solution for clinical trials, providing randomization, subject and drug supply management, and real-time reporting capabilities. Used within Sharp's clinical services to manage randomization and drug supply across clinical studies.
• Clinventory Sharp's Inventory Management System (IMS) for clinical trial supply management, providing real-time tracking and reporting capabilities for investigational medicinal products across global clinical trial operations.

Quantifiable outcome

• 140 stability programs managed for over 40 clients by single QC department (Sharp Sterile Manufacturing)
• +3 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Partnerships

Six partnerships are on record, tiered strategic and core.

• ClinsChainstrategicStrategic or Co-development Partner · 20 July 2022ClinsChain is a China-based clinical trial supply services company with operation centers in Shanghai and Beijing and a global depot network in more than 10 countries. The partnership enables Sharp to offer clinical services support to the Chinese market and provides Chinese clients with better access to Sharp's global facility network and services.
• Körber Group - Werum IT Solutions GmbHcoreTechnology or IntegrationWerum IT Solutions is Sharp's strategic MES (Manufacturing Execution System) partner. Sharp utilizes Werum's PAS-X MES solution for handling complex batch records with proven capabilities and exemplary track record in life sciences manufacturing.
• TraceLinkcoreTechnology or IntegrationTraceLink is the world's largest Track and Trace network for connecting the Life Science supply chain. Sharp and TraceLink collaborate to ensure shared clients have innovative and robust serialization solutions in place for regulatory compliance and supply chain traceability.
• SystechcoreTechnology or IntegrationSystech is the global technology leader in product safety and brand protection, having pioneered serialization. Sharp partners with Systech to unify and optimize enterprise serialization, track and trace, and authentication technologies for regulatory compliance and supply chain efficiency.
• Alliance to ZerostrategicStrategic or Co-development PartnerSharp is a founding member of Alliance to Zero, a non-profit membership association for pharma and biotech supply chain companies that aims to facilitate the transition of the sector to net-zero emissions. The association engages in collaboration with academia, non-profit organizations, and supply chain partners.
• VeevacoreTechnology or IntegrationSharp partnered with Veeva to implement QualityOne, a cloud-based quality management system across its global facility network. The partnership provides enhanced document management, training, and electronic change control capability for harmonized quality compliance across all facilities.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Catalent: Global CDMO offering sterile fill-finish, clinical supply, and commercial packaging services to biopharma. Directly comparable across Sharp's three core service lines, with a much larger footprint but similar customer base of top pharma and biotech.
• PCI Pharma Services: Contract provider of clinical and commercial packaging, serialization, and supply chain services for pharma and biotech. Closely overlaps Sharp's commercial packaging and clinical services offerings with comparable customer profiles.
• Vetter Pharma: Family-owned CDMO specializing in aseptic fill-finish of vials, syringes, and cartridges, plus lyophilization and complex packaging. Directly comparable to Sharp's sterile manufacturing and injectables packaging capabilities.
• Almac Group: Privately held CDMO offering clinical trial manufacturing, packaging, distribution, IRT, and commercial services globally. Closely matches Sharp's integrated clinical-to-commercial platform and target customer base.
• Recipharm: European-headquartered CDMO providing sterile fill-finish, oral solids, and biologics manufacturing plus clinical services. Comparable to Sharp across sterile manufacturing and commercial packaging, with broader geographic reach in Europe.
• Aenova Group: CDMO providing sterile and non-sterile manufacturing, primary and secondary packaging, and serialization for pharma. Comparable mid-sized European CDMO competing with Sharp in injectable fill-finish and packaging.
• Curia Global: CDMO offering sterile injectable fill-finish, API development, and finished dosage manufacturing. Comparable to Sharp's sterile and integrated CDMO capabilities, with overlap in small-to-mid-scale biologics programs.

Broad incumbents

• West Pharmaceutical Services: Global manufacturer of primary packaging components and delivery systems for injectable drugs, including stoppers, seals, syringes, and autoinjectors. Comparable in injectables packaging adjacency but as a component supplier rather than full-service CDMO.
• Thermo Fisher Scientific (Patheon): Large diversified CDMO and tools provider including Patheon pharma services for sterile fill-finish, clinical manufacturing, and commercial packaging. Overlaps Sharp's offering but as part of a much broader life sciences portfolio.
• Lonza Group: World's largest CDMO offering biologics manufacturing, sterile fill-finish, and cell and gene therapy services. Competes with Sharp in sterile injectables and gene therapy supply, but at substantially larger scale across modalities.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sharp-services
• Xx.com/sharp_services

Compliance13 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries4 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sharp Services